To develop and commercialise dermatology products
Alembic Pharmaceuticals (APL) has entered into joint venture agreement dated 20 April 2016 with Orbicular Pharmaceutical Technologies (Orbicular) and Dr M S Mohan to develop, manufacture and commercialise dermatology products for worldwide markets.Orbicular has capabilities in developing dermatology products with a fully equipped and staffed research laboratory in Hyderabad and has a pipeline of products at various stages of development. Manufacturing facility will be established in Aleor Dermaceuticals to enable worldwide registrations.
APL and Orbicular will own 60% and 40% of the equity capital of Aleor when the transaction is completed.
Powered by Capital Market - Live News
